Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Receivables - Net (2016 - 2026)

Conmed filings provide 17 years of Receivables - Net readings, the most recent being $228.7 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 3.4% to $228.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $228.7 million, a 3.4% increase, with the full-year FY2025 number at $247.8 million, up 4.25% from a year prior.
  • Receivables - Net hit $228.7 million in Q1 2026 for Conmed, down from $247.8 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $247.8 million in Q4 2025 to a low of $183.2 million in Q1 2022.
  • Median Receivables - Net over the past 5 years was $229.3 million (2023), compared with a mean of $223.3 million.
  • Biggest five-year swings in Receivables - Net: grew 26.62% in 2023 and later fell 8.42% in 2025.
  • Conmed's Receivables - Net stood at $191.3 million in 2022, then rose by 26.62% to $242.3 million in 2023, then decreased by 1.88% to $237.7 million in 2024, then increased by 4.25% to $247.8 million in 2025, then dropped by 7.73% to $228.7 million in 2026.
  • The last three reported values for Receivables - Net were $228.7 million (Q1 2026), $247.8 million (Q4 2025), and $224.9 million (Q3 2025) per Business Quant data.